Drug Company Warned To Stop Marketing Budesonide Nasal Spray To Treat COVID-19
SILVER SPRING, Md. — The Food and Drug Administration on Sept. 22 warned Nephron Pharmaceuticals Corp. to stop unapproved advertising that budesonide nasal asthma spray treats respiratory symptoms of COVID-19 infections....To view the full article, register now.
Already a subscriber? Click here to view full article